SME · NSE EmergeListed

KRM Ayurveda Ltd. IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 10:51 am IST · Source: Prospectus dated Tue 27 Jan 2026

Bid dates
Wed 21 Jan 2026 to Fri 23 Jan 2026
Listing date
Thu 29 Jan 2026
Issue price
₹135 per share

Listed on NSE on Thu 29 Jan 2026.

Listing price ₹172.10

Opening price on NSE on the listing day (ipocentral.in, as of Tue 17 Nov 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹135 per share
Prospectus dated Tue 27 Jan 2026, page 2
Lot size
1,000 shares
Prospectus dated Tue 27 Jan 2026, page 10
Issue size at the upper band
₹77.49 crore
Fresh issue
₹77.49 crore
Prospectus dated Tue 27 Jan 2026, page 1
Offer for sale
None
Prospectus dated Tue 27 Jan 2026, page 1
Bid dates
Wed 21 Jan 2026 to Fri 23 Jan 2026
Prospectus dated Tue 27 Jan 2026, page 82
Listing date
Thu 29 Jan 2026
Prospectus dated Tue 27 Jan 2026, page 400
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Tue 27 Jan 2026
Risk factors
74
Prospectus dated Tue 27 Jan 2026, page 74

Timeline (IST)

  1. OpensWed 21 Jan 2026, 10:00 am IST confirmedProspectus dated Tue 27 Jan 2026, page 82
  2. ClosesFri 23 Jan 2026, 3:00 pm IST confirmedProspectus dated Tue 27 Jan 2026, page 82
  3. UPI mandate cut-offFri 23 Jan 2026, 5:00 pm IST confirmedProspectus dated Tue 27 Jan 2026, page 1
  4. AllotmentTue 27 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
  5. Refund and unblockTue 27 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
  6. Shares to dematWed 28 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
  7. ListingThu 29 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400

Objects of the issue

ObjectAmount
Capital Expenditure for Construction and Development of Telemedicine Operational Facilities₹13.67 crore
Purchase of CRM Software and Hardware Infrastructure₹1.42 crore
Human Resources₹5.44 crore
Repayment/Prepayment of loan₹12.50 crore
Working Capital Requirement₹22.90 crore
General Corporate Purposes₹10.00 crore
Total₹65.92 crore

Figures may not add up due to rounding.

Prospectus dated Tue 27 Jan 2026, page 116

Company and promoters

As described in the prospectus

Our Company, established in 2019, is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.

Prospectus dated Tue 27 Jan 2026, page 196

Promoters

  • 2 individual promoters

Prospectus dated Tue 27 Jan 2026, page 305

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group92.16%Not stated in the prospectus
Public7.84%Not stated in the prospectus

Prospectus dated Tue 27 Jan 2026, page 99

Financials (restated)

ItemSeptember 30, 2025March 31, 2025March 31, 2024March 31, 2023
Revenue from operations₹48.36 crore₹76.55 crore₹67.16 crore₹89.29 crore
Profit after tax₹8.14 crore₹12.10 crore₹3.41 crore₹7.60 crore
Net worth₹36.13 crore₹23.88 crore₹11.78 crore₹8.37 crore
Total borrowings₹25.07 crore₹31.20 crore₹23.18 crore₹19.87 crore

Prospectus dated Tue 27 Jan 2026, page 28

SME issue facts

Peer comparison (as in the Prospectus)

S.noName of the companyFace Value (Rs. Per share)CMP(Rs.)EPS (Rs)P/E RatioRONW (%)NAV (Rs. Per share)PAT (Amt. In Lakhs)
1KRM Ayurveda Limited10-5.24-27.13%25.64813.92
2Jeena Sikho Lifecare Ltd.2684.208.8677.2231.28%142.2411,009.72
3Vaidya Sane Ayurved Laboratories Ltd10234.003.0776.225.12%59.85322.39

Reproduced from the Prospectus dated Tue 27 Jan 2026, page 139; InsightPier adds no figures

Risk factors

74 total
  1. The registered office and hospital premises are rented, not owned, and losing them could disrupt operations (offer document page 35)
  2. The company has a high rate of employee attrition, including frontline and technical staff (offer document page 37)
  3. Most state-wise revenue comes from two states (Delhi and Haryana), so local setbacks could hurt results (offer document page 37)
  4. The business needs a lot of working capital, and shortfalls in financing it could hurt results (offer document page 38)
  5. Being a listed company adds compliance and reporting costs that may strain resources (offer document page 74)

All 74 risk factors, pages 34 to 74

Offer document

Allotment and bids

Registrar to the issue: Skyline Financial Services Private Limited.

Allotment status is on the registrar's site, from Tue 27 Jan 2026. Pick "KRM Ayurveda Ltd." from the issue list there.

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts